Balancing the benefits and costs of antibiotic drugs: the TREAT model.
about
Synergism between Medihoney and rifampicin against methicillin-resistant Staphylococcus aureus (MRSA)Antibiotic-specific differences in the response of Staphylococcus aureus to treatment with antimicrobials combined with manuka honey.Purification and synergistic antibacterial activity of arginine derived cyclic dipeptides, from Achromobacter sp. associated with a rhabditid entomopathogenic nematode against major clinically relevant biofilm forming wound bacteria.Design and pharmacodynamics of recombinant NZ2114 histidine mutants with improved activity against methicillin-resistant Staphylococcus aureus.
P2860
Balancing the benefits and costs of antibiotic drugs: the TREAT model.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Balancing the benefits and costs of antibiotic drugs: the TREAT model.
@en
Balancing the benefits and costs of antibiotic drugs: the TREAT model.
@nl
type
label
Balancing the benefits and costs of antibiotic drugs: the TREAT model.
@en
Balancing the benefits and costs of antibiotic drugs: the TREAT model.
@nl
prefLabel
Balancing the benefits and costs of antibiotic drugs: the TREAT model.
@en
Balancing the benefits and costs of antibiotic drugs: the TREAT model.
@nl
P50
P1476
Balancing the benefits and costs of antibiotic drugs: the TREAT model
@en
P304
P356
10.1111/J.1469-0691.2010.03330.X
P577
2010-12-01T00:00:00Z